pda >>
Web | Articles | News | Videos | Home
PDA Web Results
| The 2025 Kilmer Conference | PDA
Upon the completion of the 2022 conference, Johnson & Johnson transferred sponsorship to AAMI and PDA, and these organizations have been partnering to develop the program for the 2025 Kilmer Conference. The conference agenda includes the latest developments on topics such as microbiological quality level, microbiological contamination control ...
|
| PDA Pharmaceutical Microbiology Conference 2025
Boost your brand and visibility by becoming an exhibitor at the PDA Pharmaceutical Microbiology Conference 2025! Connect with industry influencers, showcase your products and services, and position your company as a key player in the field.
|
| PDA Regulatory Conference 2025
Discover the future of regulation at PDA Regulatory Conference 2025, happening 8-10 September in Washington, DC. Join industry leaders and global regulatory authorities as we explore cutting-edge solutions and insights shaping the regulatory landscape.
|
| About PDA
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. PDA creates awareness and understanding of important issues facing the pharma community and delivers high-quality, relevant education to the industry.
|
| Q&A on the Revised PDA Technical Report No. 22 | PDA
The revised PDA Technical Report No. 22: Process Simulation for Aseptically Filled Products represents the culmination of over two-and-a-half years of dedicated effort by a team of experts from diverse backgrounds and geographical regions.
|
| PDA Pharmaceutical Microbiology Conference 2025
The Program Planning Committee invites you to submit an abstract for a podium or poster presentation at the PDA Pharmaceutical Microbiology Conference 2025. Case studies are particularly desired. We are seeking abstracts on a wide variety of topics, including but not limited to:
|
| PDA Visual Inspection Forum 2025
At the PDA Visual Inspection Forum, you'll experience a unique multi-faceted learning experience: Regulatory Evolution: Stay current on the complex regulatory environment through expert presentations, case studies, and in-depth reviews of the latest academic research.
|
| Understanding Japan Quality | PDA
PDA Journal of GMP and Validation in Japan Vol. 17, No 1 Japanese Pharmaceutical Affairs Law, Chapter IX, Section 2, Handling of Pharmaceuticals, Article 56 Prohibition of Sale and Manufacturing. https://www.japaneselawtranslation.go.jp/en/laws/view/3213/en#je_ch9sc2at10 (accessed July 4 th 2024)
|
|